News

There’s likely to be a fundamental difference between how a medical practicioner and an artist view genetic editing with CRISPR. But both perspectives reveal possible ways to shape life in nature. Science meets art: the Max Delbrück Center at the Salon Sophie Charlotte 2022 in Berlin.

The Max Delbrück Center for Molecular Medicine and the Otto von Guericke University Magdeburg and will cooperate in the field of medical imaging in the future. A cooperation agreement was signed on Friday, 11 March 2022 at the Research Campus in Berlin-Buch.

High-throughput methods that help search for new cancer drugs often rely on oversimplified models. For example, they do not account for the most common cell states found in patients with cancer. MDC researcher Gaetano Gargiulo has now received an ERC Proof of Concept Grant to seek a solution to this problem.

COVID-19 and cardiovascular health, cell diagnostics of the future and new methods for reducing animal testing: MDC scientists will present their work at Berlin Science Week. At PostDoc Day, young researchers from all over Berlin can exchange ideas with each other.

T-knife, a spin-off from the MDC and Charité, has raised 110 million U.S. dollars from international investors. The Berlin-based biotech company is developing novel immunotherapies against cancer that focus on teaching a patient’s T cells to recognize and fight solid tumors.

It’s nice that virtual events are now second nature to us. So this year, too, science enthusiasts won’t have to miss out on the “smartest night of the year.” On June 5, 2021, the MDC will offer a glimpse into its research – completely digitally.

Researchers from the MDC and Charité have developed a new gene therapy based around a special T-cell receptor that helps the immune system effectively recognize and fight cancer cells. The safety of the novel therapy is now being tested on patients with bone marrow cancer in a phase I clinical trial.

On November 7, 2020, the Berlin Institute of Health (BIH) and the Tagesspiegel are hosting the fifth edition of the Future Medicine Science Match. This year’s focus is “Artificial Intelligence in Translational Medicine.” MDC researcher Roland Schwarz is chair of the session on AI in basic research.

When virologists become reality TV stars, biologists dream of life without illness, researchers debate organoids vs. animal testing with the general public, and biomedical scientists discuss the possibilities of AI, it can only be Berlin Science Week. This year, the MDC is holding a number of virtual events.

The Berlin biotech start-up T-knife, a spin-off from the MDC together with Charité, has secured investments totaling €66 million. Four venture capital funds committed to the financing in early August. T-knife develops new cancer treatments using modified immune system T cells.